Search
Filter Results
- Resource Type
- Article1
- Database1
- Exam Prep1
- Article Type
- Clinical Trial1
- Randomized Controlled Trial1
- Clinical Study1
- Comparative Study1
- Result From
- Lane Catalog1
- PubMed1
-
Year
- Journal Title
- Am J Dis Child1
Search Results
Sort by
- DatabaseSummary: "The 15 virtual patient cases in Aquifer Neurology provide coverage of the clerkship guidelines endorsed by the American Academy of Neurology."--Website.Digital Access DatabaseUsers must register with their Stanford email and login. If you get "email address is unknown" contact Mary.Buttner at stanford.edu.
- ArticleHoward JB, Howard JE.Am J Dis Child. 1978 Nov;132(11):1085-7.A total of 118 children between 6 months and 10 years of age with acute urinary tract infection were treated in a random; double-blind manner with 12 mg/kg/day of trimethoprim-sulfamethoxazole (61 patients) or 50 mg/kg/day of sulfamethoxazole (57 patients) for ten days. Mean trimethoprim and sulfamethoxazole susceptibilities of Escherichia coli isolated from these patients were 1.2 and 0.6 microgram/ml, respectively. Mean serum concentrations of trimethoprim and sulfamethoxazole were 1.8 and 62 microgram/ml, respectively, one hour after the dose. Of the children who completed the ten days of prescribed medication, clinical and bacteriological cure was confirmed immediately after treatment for all but one patient in each group. Most patients in each treatment group with recurrent infections had underlying urological abnormalities. Severe hematological, renal, or hepatic toxicity requiring interruption of treatment was not encountered. No advantage of trimethoprim-sulfamethoxazole over sulfamethoxazole alone for acute urinary tract infection was demonstrated.